Myanmar, also known as Burma, is a country in Southeast Asia that is home to over 54 million people. The Lipid-Lowering Agents market in Myanmar has been developing rapidly in recent years, driven by various factors such as changing customer preferences, local special circumstances, and underlying macroeconomic factors.
Customer preferences: Myanmar has a high prevalence of cardiovascular diseases, which has led to an increase in demand for Lipid-Lowering Agents. Furthermore, the country has a growing middle class who are becoming more health-conscious and willing to spend on preventative healthcare. As a result, there has been a shift towards more expensive branded drugs, which offer better quality and efficacy compared to generic drugs.
Trends in the market: One of the main trends in the Lipid-Lowering Agents market in Myanmar is the increasing availability of new drugs. Pharmaceutical companies are launching new drugs in the market, which are more effective and have fewer side effects compared to traditional drugs. This has led to increased competition among drug manufacturers and a decrease in prices, making drugs more affordable for the general population.Another trend is the increasing use of online pharmacies. Online pharmacies have become popular in Myanmar due to the convenience they offer, especially in rural areas where access to healthcare facilities is limited. Online pharmacies also offer a wider range of drugs at lower prices, which has increased accessibility to Lipid-Lowering Agents for a larger population.
Local special circumstances: Myanmar faces unique challenges in its healthcare system due to its geography and infrastructure. The country has a large rural population with limited access to healthcare facilities, making it difficult to provide healthcare services to all its citizens. Furthermore, the country has a weak regulatory system, which has led to the proliferation of counterfeit drugs in the market. This has created a lack of trust among consumers, who are wary of purchasing drugs from unregulated sources.
Underlying macroeconomic factors: Myanmar has experienced significant economic growth in recent years, which has led to an increase in disposable income and a growing middle class. This has resulted in increased demand for healthcare services, including Lipid-Lowering Agents. Furthermore, the government has been investing in healthcare infrastructure, which has led to an increase in the availability of healthcare services in the country. However, the country still faces challenges such as a shortage of healthcare professionals and inadequate healthcare funding, which has limited the growth of the healthcare sector.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
